Key takeaway
In 100 patients with obesity and hypertension, 83.7% (41 of 49) of those randomized to gastric bypass plus medication cut their antihypertensive drugs by at least 30% while keeping blood pressure controlled at 12 months, versus 12.8% (6 of 47) on medication alone (rate ratio 6.6, 95% CI 3.1-14.0). It was a single-center, unblinded trial with one year of follow-up, so long-term effects and safety are not shown here.
Study design
Randomised trial
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
The research question
Bariatric surgery has mostly been studied for diabetes and weight, and randomized trials of its effect in people with obesity and hypertension were needed. The authors tested whether gastric bypass added to medical therapy lowers the amount of blood pressure medication needed, compared with medical therapy alone.
Who and how
Randomized, single-center, nonblinded trial in patients with hypertension (using at least 2 medications at maximum doses or more than 2 at moderate doses) and a body mass index between 30.0 and 39.9 kg/m2. Patients were randomized to Roux-en-Y gastric bypass plus medical therapy or medical therapy alone. The primary end point was a reduction of at least 30% in the total number of antihypertensive medications while keeping blood pressure below 140/90 mm Hg at 12 months.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1100 patients were included (70% female, mean age 43.8 years, mean BMI 36.9 kg/m2) and 96% completed follow-up.
- 2The primary end point was met by 41 of 49 patients (83.7%) in the gastric bypass group versus 6 of 47 (12.8%) in the control group (rate ratio 6.6, 95% CI 3.1-14.0; P <0.001).
- 3Hypertension remission occurred in 25 of 49 (51%) by office readings and 22 of 48 (45.8%) by 24-hour ambulatory monitoring after surgery, while no patient on medical therapy alone was free of antihypertensive drugs.
- 4A post hoc analysis using the SPRINT blood pressure target gave a rate ratio of 3.8 (95% CI 1.4-10.6; P =0.005), and 11 surgical patients (22.4%) reached SPRINT levels without drugs versus none in the control group.
- 5Waist circumference, BMI, fasting glucose, glycohemoglobin, LDL cholesterol, triglycerides, high-sensitivity C-reactive protein and 10-year Framingham risk score were lower after surgery than in controls.
Limits & uncertainty
- 1Single center and nonblinded, so patients and doctors knew the treatment, which may influence medication decisions that make up the primary end point.
- 2Follow-up was 12 months; the abstract does not report longer-term blood pressure, complications or whether remission lasts.
- 3The primary end point counts medication reduction with controlled pressure, not heart attacks, strokes or deaths.
- 4The SPRINT-target analysis was post hoc, and this reading is based on the abstract only.
What to take from it
For people with obesity and hard-to-control hypertension, surgery cut the drug burden a lot in this trial, but it is a major operation whose risks the abstract does not describe. Whether surgery is appropriate is a decision for the patient and their clinician, not something to infer from one trial.
Reading your own data
A validated home cuff, used at the same time of day and averaged over several days, is the right way to follow blood pressure. Weight and waist logs show the other changes measured here. Do not change medication based on home numbers without your clinician.
How to read this evidence
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Recent research efforts on bariatric surgery have focused on metabolic and diabetes mellitus resolution. Randomized trials designed to assess the impact of bariatric surgery in patients with obesity and hypertension are needed.
Methods
In this randomized, single-center, nonblinded trial, we included patients with hypertension (using ≥2 medications at maximum doses or >2 at moderate doses) and a body mass index between 30.0 and 39.9 kg/m^(2). Patients were randomized to Roux-en-Y gastric bypass plus medical therapy or medical therapy alone. The primary end point was reduction of ≥30% of the total number of antihypertensive medications while maintaining systolic and diastolic blood pressure <140 mm Hg and 90 mm Hg, respectively, at 12 months.
Results
We included 100 patients (70% female, mean age 43.8±9.2 years, mean body mass index 36.9±2.7 kg/m2), and 96% completed follow-up. Reduction of ≥30% of the total number of antihypertensive medications while maintaining controlled blood pressure occurred in 41 of 49 patients from the gastric bypass group (83.7%) compared with 6 of 47 patients (12.8%) from the control group with a rate ratio of 6.6 (95% confidence interval, 3.1-14.0; P <0.001). Remission of hypertension was present in 25 of 49 (51%) and 22 of 48 (45.8%) patients randomized to gastric bypass, considering office and 24-hour ambulatory blood pressure monitoring, respectively, whereas no patient submitted to medical therapy was free of antihypertensive drugs at 12 months. A post hoc analysis for the primary end point considering the SPRINT (Systolic Blood Pressure Intervention Trial) target reached consistent results, with a rate ratio of 3.8 (95% confidence interval, 1.4-10.6; P =0.005). Eleven patients (22.4%) from the gastric bypass group and none in the control group were able to achieve SPRINT levels without antihypertensives. Waist circumference, body mass index, fasting plasma glucose, glycohemoglobin, low-density lipoprotein cholesterol, triglycerides, high-sensitivity C-reactive protein, and 10-year Framingham risk score were lower in the gastric bypass than in the control group.
Conclusions
Bariatric surgery represents an effective strategy for blood pressure control in a broad population of patients with obesity and hypertension.
Clinical trial registration
URL: https://clinicaltrials.gov. Unique identifier: NCT01784848.
Sources & attribution
Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).
Schiavon CA, Bersch-Ferreira AC, Santucci EV, Oliveira JD, Torreglosa CR, Bueno PT, Frayha JC, Santos RN, Damiani LP, Noujaim PM, Halpern H, Monteiro FLJ, Cohen RV, Uchoa CH, de Souza MG, Amodeo C, Bortolotto L, Ikeoka D, Drager LF, Cavalcanti AB, Berwanger O.
Circulation · 2017-11-13
DOI: 10.1161/circulationaha.117.032130 ↗PubMed · 29133606 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

